Kaneshima Hideto
Chief Technical Advisor & Doctor of Medicine @ CellSource
Kaneshima Hideto is a startup investor at CellSource. Born in 1952, he was born in Niigata Prefecture. Doctor, Doctor of Medicine. Graduated from Nagoya University School of Medicine in 1978. Completed the Department of Pathology and Immunology in 1983. He studied at Stanford University School of Medicine in the United States since 1986. Leading professor and bio-venture company Sysomix founded inSilicon Valley, SaiboBaiyo Ni Yoru ShokuryoSeisan He, including gene therapy, cell transplant therapy, etc. . We also succeeded in IPO and experienced international R&D such as a subsidiary of Novartis Corporation. After that, he became independent as a consultant in the field of biotechnology and promoted the bio-healthcare business in Japan while supporting many companies across Japan and the United States. In 2016, he became the director and CSO of CellSource Co., Ltd. SaiboBaiyo Ni Yoru ShokuryoSeisan He wants to contribute to the practice of new treatments using adipose tissue and its stem cells.
Last updated:
For AI agents: llms.txt
About CellSource
CellSource provides adipose-derived stem cell processing services, blood-derived processing contract services, and support services for compliance with laws and regulations in areas such as regenerative medicine.
CellSource Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hideo Koyama
Auditor
|
|||
|
Hirohiko Hanaki
Director, Chief Compliance Officer (CCO) & Head of Regenerative Medicine Business Division
|
|||
|
Kaneshima Hideto
Chief Technical Advisor & Doctor of Medicine
|
|||
Kenta Fujita
Executive Officer
|
|||
Masahiro Samejima
General Counsel and Patent Attorney
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
